Nanologica AB (publ) (FRA:4YD)

Nanologica AB Statistics

Total Valuation

Nanologica AB has a market cap or net worth of EUR 7.36 million. The enterprise value is 10.49 million.

Market Cap	7.36M
Enterprise Value	10.49M

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	88.37M
Shares Outstanding	n/a
Shares Change (YoY)	+110.85%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	10.95%
Owned by Institutions (%)	17.52%
Float	32.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.59
PB Ratio	2.01
P/TBV Ratio	2.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.44
EV / Sales	5.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.07

Financial Position

The company has a current ratio of 2.50, with a Debt / Equity ratio of 1.19.

Current Ratio	2.50
Quick Ratio	0.54
Debt / Equity	1.19
Debt / EBITDA	n/a
Debt / FCF	-0.86
Interest Coverage	-9.50

Financial Efficiency

Return on equity (ROE) is -300.58% and return on invested capital (ROIC) is -77.58%.

Return on Equity (ROE)	-300.58%
Return on Assets (ROA)	-33.16%
Return on Invested Capital (ROIC)	-77.58%
Return on Capital Employed (ROCE)	-75.17%
Revenue Per Employee	107,808
Profits Per Employee	-226,194
Employee Count	16
Asset Turnover	0.23
Inventory Turnover	0.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.38% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-50.38%
50-Day Moving Average	0.08
200-Day Moving Average	0.09
Relative Strength Index (RSI)	33.46
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nanologica AB had revenue of EUR 2.05 million and -4.30 million in losses. Loss per share was -0.05.

Revenue	2.05M
Gross Profit	449,721
Operating Income	-4.71M
Pretax Income	-4.30M
Net Income	-4.30M
EBITDA	-4.88M
EBIT	-4.71M
Loss Per Share	-0.05

Balance Sheet

The company has 1.26 million in cash and 4.37 million in debt, giving a net cash position of -3.10 million.

Cash & Cash Equivalents	1.26M
Total Debt	4.37M
Net Cash	-3.10M
Net Cash Per Share	n/a
Equity (Book Value)	3.66M
Book Value Per Share	0.04
Working Capital	4.32M

Cash Flow

In the last 12 months, operating cash flow was -4.98 million and capital expenditures -78,873, giving a free cash flow of -5.06 million.

Operating Cash Flow	-4.98M
Capital Expenditures	-78,873
Free Cash Flow	-5.06M
FCF Per Share	n/a

Margins

Gross margin is 21.96%, with operating and profit margins of -230.00% and -209.81%.

Gross Margin	21.96%
Operating Margin	-230.00%
Pretax Margin	-209.81%
Profit Margin	-209.81%
EBITDA Margin	-238.45%
EBIT Margin	-230.00%
FCF Margin	n/a

Dividends & Yields

Nanologica AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-110.85%
Shareholder Yield	-110.85%
Earnings Yield	-58.41%
FCF Yield	-68.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nanologica AB has an Altman Z-Score of -5.22 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.22
Piotroski F-Score	3